Balloon that delivers medicine directly to heart arteries could offer Stent-Free option

NCT ID NCT04470934

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study evaluates a special balloon coated with sirolimus, a drug that helps prevent arteries from narrowing again after angioplasty. The balloon is used during routine procedures to open blocked heart arteries in people with coronary artery disease. Researchers are tracking how well it works and its safety in real-world use, focusing on whether it reduces heart attacks or the need for repeat treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a sirolimus-coated balloon catheter that delivers the drug directly to the artery wall during angioplasty
What this could lead to
If successful, this could offer a stent-free option for treating coronary artery disease, reducing the need for repeat procedures.
What could go wrong
This is an observational study without a comparison group, so results may not prove superiority over existing treatments. Risks include artery injury, blood clots, or the drug not preventing re-narrowing as expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Universitätsklinikum Jena

    Jena, Thuringia, 07747, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.